OSLO, Norway, Aug. 14, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announced that the U.S. Food and Drug Administration (FDA) has published a proposed order in the Federal Register to initiate the process of reclassifying cystoscopic systems intended as an aid for the detection of bladder cancer from Class III to Class II. Importantly, FDA is initiating the proposed reclassification on its own initiative following its review of available scientific, clinic

万众瞩目！” ——前言 “和你的期待一致吗？” 立项指南的落地，终于迎来了最终章！ 今天，国家医保局正式发布了《检验类医疗服务价格项目立项指南（试行）》 总计662个主项、114个加收项、7个扩展项，信息量多到爆炸。 详细的分析我们下周会做。 类似于“AI继续待在价格构成”、“质谱回归了”这些今天没时间展开。 先聊一聊几个最好玩的点： 1. 联检的“犹抱琵琶半遮面” 2. 分子诊断的“大分家” 3. 价格的“大乱斗” PS：仅代表个人观点，欢迎留言探讨。 01 “联检，打折！” 联检的打折，是必然要执行的。 征求意见稿中那个高考难度的联检计算公式，大家应该都很头疼，毕竟我们早就过了人生数学的巅峰期。 正式稿非常友好的将计算难度降到了幼儿园大班水平： 5个及以内，打八折；6-10个，打7折；11个及以上，打6折； 但是，对于联检的定义依然是“犹抱琵琶半遮面”。 相比于征求意见稿多了说明，但要说界定的非常清晰，那也是没有。 大家细品这句话： 联检指医疗机构利用联检试剂或检测平台，通过一次检验操作对同一份样本中的多个待测指标进行联合检测。 其中，联检试剂有一个相对可查的标准： 国家医保局《医

点击上方的 行舟Drug ▲ 添加关注 文章信息源于公众号Biologics CMC，登载该文章目的为更广泛的传递行业信息，不代表赞同其观点或对其真实性负责。文章版权归原作者及原出处所有，文章内容仅供参考。本网拥有对此声明的最终解释权，若无意侵犯版权，请联系小编删除。 学如逆水行舟，不进则退； 心似平原走马，易放难收。 行舟Drug 每日更新 欢迎订阅+ 医药大数据|行业动态|政策解读

2026年8月14日，在第十九届健康产业生态大会（西普会）现场，中康科技正式发布HealthLink AI生态社区。 腾讯健康、百度智能云，阿里巴巴千问等头部AI企业及来自医药、医疗、科研和技术领域的生态伙伴齐聚现场，共同探索人工智能与医药健康产业深度融合的新路径。 HealthLink AI定位为医药健康产业数智化AI共生生态与价值赋能平台，以中康自研”卓睦鸟医疗大模型“为核心，连接产业数据、模型能力、技术工具、真实场景与生态伙伴，构建从临床到商业化的全链路产业价值闭环。 AI正从单点应用走向生态协同 过去几年，大模型、智能体和各类AI应用加速涌入健康产业。越来越多企业具备了模型、算法和技术工具，医院、药企、医药零售企业也涌现出大量智能化需求。然而，在真实产业环境中，数据、技术与业务场景之间仍存在明显断层。 一方面，医院、药企和医药零售企业手握真实业务需求，却难以快速判断哪些AI能力真正适配自身场景；另一方面，AI技术企业、科研机构和开发者拥有专业能力，却往往缺少高质量产业数据、真实验证环境和规模化商业通路。 AI在健康产业的下一程，已不再是单个模型或产品的竞争，而是数据、模型、场景

2026年8月14日，在第十九届健康产业生态大会（西普会）现场，中康科技正式发布新药研发智能体 Deep Pharma——一款专为医药研发、BD、产业投资团队打造的AI智能体产品，标志着中康的业务从药品商业化数智服务延伸至新药研发全链条，以 AI 能力赋能从药物研发立项到商业化决策全链路。 Deep Pharma 的五大核心能力，覆盖研发决策全场景 01.竞争格局分析 根据用户希望调研的具体领域（如疾病、靶点、药物类型等），Deep Pharma会从作用机理、现有疗法、竞争格局、临床有效性、安全性、依从性等多维度评估，并输出专家级SWOT分析。相较传统数据库的单一检索能力，Deep Pharma基于多智能体协作架构，自动完成数据收集→证据链核查→深度分析→交付级报告生成的全流程，清晰呈现全球范围内各厂商项目布局、研发阶段、最新进展，快速掌握赛道全局。 02.中康 19 年积累的强大数据基座 Deep Pharma构建于中康沉淀的扎实数据底座，覆盖全球7万+新药活跃管线、1.8万+ 靶点数据、70万+ 临床试验记录及4000万+ 文献/会议数据的深厚积累，覆盖从Discovery到上市的

JERSEY CITY, N.J., Aug. 14, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that it has closed its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of pre-funded warrants to purchase an aggregate of

BALTIMORE, Aug. 14, 2026 /PRNewswire/ -- Nanochon, a medical device company developing Chondrograft™, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá's Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá. The study will evaluate the safety and performance of Chondrograft™ in patients with focal chondral defects of the knee and represents a major milestone in th

San Diego-based biotech pioneer shortlisted for the Prix Galien - having shown tremendous potential to improve human health SAN DIEGO , Aug. 14, 2026 /PRNewswire/ -- BioSapien, the pioneering biotech company, is delighted to announce it has been nominated by The Galien Foundation – the premier global institution dedicated to honoring innovators in life sciences - in the "Best Startup" category, for the 20th Prix Galien USA Awards. Continue Reading BioSapien, the pioneering biotech company, no

JOPLIN, Mo., Aug. 14, 2026 /PRNewswire/ -- Missouri Southern State University (MSSU) students lined the grand staircase of the Roy Blunt Health Science Innovation Center on Aug. 13 to celebrate the facility's grand opening and ribbon-cutting alongside community members, university leaders and the building's namesake, former U.S. Sen. Roy Blunt. The grand opening marks the completion of a transformational facility designed to prepare students for careers in the rapidly evolving healthcare field.

This discovery by Whitehead Institute Member Ankur Jain and colleagues points toward new combination strategies against cancer, and offers a possible explanation for the iron buildup seen in disorders such as early-onset Parkinson's disease. CAMBRIDGE, Mass., Aug. 14, 2026 /PRNewswire/ -- Iron is essential. Our cells need it to produce energy, carry oxygen throughout the body, and power countless chemical reactions that sustain life. But this metal has a dark side. When too much of it is left fr